{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T05:21:29Z","timestamp":1793337689994,"version":"4.5.0"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["JAHA"],"published-print":{"date-parts":[[2017,1,11]]},"abstract":"<jats:sec xml:lang=\"en\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p xml:lang=\"en\">\n                      Optimal timing of implantation of an implantable cardioverter\/defibrillator (\n                      <jats:styled-content style=\"fixed-case\">ICD<\/jats:styled-content>\n                      ) after newly diagnosed heart failure is unclear given that late reverse remodelling may occur. We aimed to analyze left ventricular ejection fraction (\n                      <jats:styled-content style=\"fixed-case\">LVEF<\/jats:styled-content>\n                      ) after diagnosis of an\n                      <jats:styled-content style=\"fixed-case\">LVEF<\/jats:styled-content>\n                      \u226435% during optimization of heart failure drug therapy.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec xml:lang=\"en\">\n                    <jats:title>Methods and Results<\/jats:title>\n                    <jats:p xml:lang=\"en\">\n                      One hundred fifty\u2010six patients with newly diagnosed\n                      <jats:styled-content style=\"fixed-case\">LVEF<\/jats:styled-content>\n                      \u226435% receiving a wearable cardioverter\/defibrillator (\n                      <jats:styled-content style=\"fixed-case\">WCD<\/jats:styled-content>\n                      ) were analyzed.\n                      <jats:styled-content style=\"fixed-case\">WCD<\/jats:styled-content>\n                      was prescribed for 3\u00a0months until first re\u2010evaluation. Indications for prolongation of\n                      <jats:styled-content style=\"fixed-case\">WCD<\/jats:styled-content>\n                      wearing period instead of\n                      <jats:styled-content style=\"fixed-case\">ICD<\/jats:styled-content>\n                      implantation were: (1)\n                      <jats:styled-content style=\"fixed-case\">LVEF<\/jats:styled-content>\n                      at 3\u2010month visit 30% to 35%; (2) increase in\n                      <jats:styled-content style=\"fixed-case\">LVEF<\/jats:styled-content>\n                      of \u22655% compared to the last visit; and (3) nonoptimized heart failure medication. Mean\n                      <jats:styled-content style=\"fixed-case\">LVEF<\/jats:styled-content>\n                      was 24\u00b17% at diagnosis and 39\u00b111% at last follow\u2010up (mean, 12\u00b110\u00a0months). Whereas 88 patients presented a primary preventive\n                      <jats:styled-content style=\"fixed-case\">ICD<\/jats:styled-content>\n                      indication (\n                      <jats:styled-content style=\"fixed-case\">LVEF<\/jats:styled-content>\n                      \u226435%) at 3\u2010month follow\u2010up, only 58 showed a persistent primary preventive\n                      <jats:styled-content style=\"fixed-case\">ICD<\/jats:styled-content>\n                      indication at last follow\u2010up. This delayed improvement in\n                      <jats:styled-content style=\"fixed-case\">LVEF<\/jats:styled-content>\n                      was related to nonischemic origin of cardiomyopathy, New York Heart Association functional class at baseline, heart rate, better\n                      <jats:styled-content style=\"fixed-case\">LVEF<\/jats:styled-content>\n                      after 3\u00a0months, and higher dosages of mineralocorticoid receptor antagonist. Twelve appropriate\n                      <jats:styled-content style=\"fixed-case\">WCD<\/jats:styled-content>\n                      shocks for ventricular tachycardia\/ventricular fibrillation occurred in 11 patients. Two patients suffered from ventricular tachycardia\/ventricular fibrillation beyond 3\u00a0months after diagnosis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec xml:lang=\"en\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p xml:lang=\"en\">\n                      A relevant proportion of patients with newly diagnosed heart failure shows recovery of\n                      <jats:styled-content style=\"fixed-case\">LVEF<\/jats:styled-content>\n                      &gt;35% beyond 3\u00a0months after initiation of heart failure therapy. To avoid untimely\n                      <jats:styled-content style=\"fixed-case\">ICD<\/jats:styled-content>\n                      implantation, prolongation of\n                      <jats:styled-content style=\"fixed-case\">WCD<\/jats:styled-content>\n                      period should be considered in these patients to prevent sudden cardiac death while allowing left ventricular reverse remodeling during intensified drug therapy.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1161\/jaha.116.004512","type":"journal-article","created":{"date-parts":[[2017,1,17]],"date-time":"2017-01-17T21:52:15Z","timestamp":1484689935000},"update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":85,"title":["Avoiding Untimely Implantable Cardioverter\/Defibrillator Implantation by Intensified Heart Failure Therapy Optimization Supported by the Wearable Cardioverter\/Defibrillator\u2014The PROLONG Study"],"prefix":"10.1161","volume":"6","author":[{"given":"David","family":"Duncker","sequence":"first","affiliation":[{"name":"Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorben","family":"K\u00f6nig","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Hohmann","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johann","family":"Bauersachs","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Veltmann","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv316"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.592"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa041489"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0901889"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2012.07.004"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa043938"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.114.009924"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/pace.12868"},{"key":"e_1_3_2_10_2","first-page":"69","article-title":"The wearable cardioverter\/defibrillator\u2014Toy or Tool?","volume":"8","author":"Duncker D","year":"2016","unstructured":"Duncker D, Veltman C. The wearable cardioverter\/defibrillator\u2014Toy or Tool? J Atr Fibrillation. 2016;8:69\u201377.","journal-title":"J Atr Fibrillation"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehs104"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/eht514"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2011.01.027"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2015.12.042"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2011.05.033"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2014.03.025"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/eut097"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2010.1915"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.663807"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2015.02.035"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000121328.12536.07"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurjhf\/hft134"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.252"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.188"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12181-015-0651-y"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000394"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euv191"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1608029"}],"container-title":["Journal of the American Heart Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/JAHA.116.004512","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T06:43:50Z","timestamp":1715582630000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/JAHA.116.004512"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,11]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1,11]]}},"alternative-id":["10.1161\/JAHA.116.004512"],"URL":"https:\/\/doi.org\/10.1161\/jaha.116.004512","relation":{},"ISSN":["2047-9980"],"issn-type":[{"value":"2047-9980","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,11]]},"assertion":[{"value":"2016-08-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-12-14","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-01-17","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e004512"}}